Zealand Pharma A/S
ZLDPF
$75.88
-$7.17-8.63%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -99.44% | 121,008.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -99.44% | 121,008.05% | |||
| Cost of Revenue | -- | 9.28% | |||
| Gross Profit | -99.44% | 127,391.11% | |||
| SG&A Expenses | 77.93% | 15.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | 773.85% | |||
| Total Operating Expenses | -29.84% | 94.78% | |||
| Operating Income | -105.70% | 2,309.05% | |||
| Income Before Tax | -104.66% | 2,697.56% | |||
| Income Tax Expenses | -92.81% | 42,209.17% | |||
| Earnings from Continuing Operations | -105.50% | 2,535.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -105.50% | 2,535.43% | |||
| EBIT | -105.70% | 2,309.05% | |||
| EBITDA | -105.60% | 2,343.54% | |||
| EPS Basic | -105.53% | 2,531.09% | |||
| Normalized Basic EPS | -104.90% | 2,562.19% | |||
| EPS Diluted | -105.61% | 2,497.72% | |||
| Normalized Diluted EPS | -104.97% | 2,528.39% | |||
| Average Basic Shares Outstanding | -0.60% | 0.19% | |||
| Average Diluted Shares Outstanding | -1.97% | 1.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||